Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)-Reference-Cited by-同舟云学术

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Published:2021 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Borobia Alberto M,Carcas Antonio J,Pérez Olmeda María Teresa,Castaño Luis,Jesús Bertrán María,García-Pérez Javier,Campins Magdalena,Portolés Antonio,Gonzalez-Perez Maria,García Morales María Teresa,Arana Eunate,Aldea Novo Marta,Díez-Fuertes Francisco,Fuentes-Camps Inmaculada,Ascaso Ana,Lora David,Imaz-Ayo Natale,Baron-Mira Lourdes E,Agustí Antonia,Pérez-Ingidua Carla,Gómez de la Cámara Agustín,Arribas JR,Ochando Jordi,Alcamí Pertejo José,Belda-Iniesta Cristóbal,Frías Jesús,Group CombiVacS Study

Publisher

Elsevier BV

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval;Vaccine;2024-11

2. Omicron variant evolved: Signs, symptoms and complications;RECENT ADVANCES IN SCIENCES, ENGINEERING, INFORMATION TECHNOLOGY & MANAGEMENT;2023

3. Reporting and data sharing level for COVID-19 vaccine trials: A cross-sectional study;eBioMedicine;2022-04

4. Dynamic changes in the concentration of anti-SARS-CoV-2 antibodies within 12 months after recovery from COVID-19;Bulletin of Russian State Medical University;2022-02

5. Vaccine-induced immune responses against SARS-CoV-2 infections;Exploration of Immunology;2021-12-09